Abraxis BioScience, Inc. Appoints David O’Toole as Chief Financial Officer

LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABII), an integrated, global biotechnology company, today announced that David O’Toole has been appointed Executive Vice President and Chief Financial Officer, succeeding Lisa Gopala.